Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Hematopoietic cell transplantation for adult patients with myelodysplastic syndromes and myeloproliferative disorders.
Benesch M, Deeg HJ. Benesch M, et al. Mayo Clin Proc. 2003 Aug;78(8):981-90. doi: 10.4065/78.8.981. Mayo Clin Proc. 2003. PMID: 12911046 Review.
Hematopoietic cell transplantation (HCT) is currently the only treatment with curative potential for myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD). Among patients with less advanced MDS, 3-year survival rates of 65% to 75% are achieved with HLA-ide …
Hematopoietic cell transplantation (HCT) is currently the only treatment with curative potential for myelodysplastic syndromes (MDS) and mye …
Hemopoietic cell transplantation as curative therapy of myelodysplastic syndromes and myeloproliferative disorders.
Scott B, Deeg HJ. Scott B, et al. Best Pract Res Clin Haematol. 2006;19(3):519-33. doi: 10.1016/j.beha.2005.07.009. Best Pract Res Clin Haematol. 2006. PMID: 16781487
Hemopoietic cell transplantation (HCT) is presently the only therapy with curative potential for myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD). Among patients with less advanced MDS, 3-year survival figures of 65-80% are achieved with human leukocy …
Hemopoietic cell transplantation (HCT) is presently the only therapy with curative potential for myelodysplastic syndromes (MDS) and myelopr …